MAXQ AI TEAM

THE MAXQ AI TEAM OF ARTIFICIAL INTELLIGENCE, DEEP LEARNING, AND MACHINE VISION EXPERTS – TOGETHER WITH OUR DEDICATED BOARD OF DIRECTORS AND SCIENTIFIC AND MEDICAL ADVISORY BOARD – ARE CHANGING THE STANDARDS OF EMERGENCY ROOM TREATMENT AND COST OF CARE.

MICHAEL ROSENBERG

Co-Founder & CEO

Michael is the co-founder and CEO of MaxQ AI.  Prior to Michael’s role as CEO, Michael served as CFO of the company since its founding in October 2013. Michael has previously served as CFO of Pursway, Ltd., a Battery Ventures-backed machine learning/big influencer marketing company from June 2010 until August 2014  (acq. by IPG Media Brands). Michael has also held several executive positions in the telecommunications and eCommerce industries. Roles included Executive Vice President at TeleContinuity, Inc. from August 2003 through October 2009, Vice President of Professional Services and Corporate Development of Elcom International (NASDAQ:ELCO) from June 1994 until July 2003. Michael earned a BA in Economics from Yeshiva University.

ROBERT MEHLER

Co-Founder, Chief Operating Officer,
& Chief Information Security Officer

Prior to MaxQ, Robert served as Vice President, Business Operations at GENBAND fring (NASDAQ: RBBN).  Additionally, Robert served as Vice President, Customer Operations at ActivePath, Inc. (acquired by: Broadridge Financial Solutions) Robert held senior management positions at ObserveIT (acquired by: Proofpoint), Correlix (acquired by: TS Associates), Gotham Technology Group, Martha Stewart Living Omnimedia. At Genesis Venture Capital Partners, Robert participated in investments for Kidaro (acquired by: Microsoft) and Correlix acquired by: TS-Associates). Robert holds a B.A. in Middle Eastern Studies and Languages from Columbia University.

CHRIS SCHNEE

Chief Commercial Officer

22+ years of global commercial leadership, sales, marketing, and business operations experience within healthcare, medical device, medical imaging, and industrial market sectors. Prior to joining MaxQ AI served as VP Global Marketing and International Sales, Centurion Medical and General Manager, Christie Medical Holdings.

DR. JOSHUA SCHULMAN

VP Clinical, Regulatory
and Quality Affairs

18+ years of clinical R&D and worldwide regulatory experience in imaging, medical devices and pharmaceuticals for academia, government and industry. PhD in Neurobiology.

Jorge Zapata

VP Customer Success

25+ years of technology and healthcare innovation expertise. Prior to MaxQ AI, Jorge held strategic leadership, service innovations, and service delivery positions at Phillips Healthcare and Siemens.

ROEE SHIBOLET

VP Research & Development

18+ years of Software and Algorithm R&D leadership in the Medical Device field. Prior to MaxQ AI, Roee managed the Software development group in Medinol, developing high magnification automatic visual inspection systems.

MAYA MICHELSOHN

VP Finance

18+ years of finance experience for large corporate and banking institutions on a global basis. Extensive experience in public company financial reporting and controls. Most recently, Director, Corporate Finance at Teva Pharmaceuticals. Certified Public Accountant.

Steve Kohlmyer

VP Research and Collaborations

28+ years of innovation in medical device development. Prior to MaxQ AI, Steve was a leader in CT and PET/CT product development at GE Healthcare, and was CTO for thoracic image processing at Imbio.

Scientific and Medical Advisory Board


Dr. Gabriel Polliack

Chairman of the National Imaging Council Committee for Sharing of Diagnostic Images

Dr Ajay Choudhri

Capital Health – New Jersey
Director, Vascular and Interventional Radiology
Radiology, Assistant Director
Radiology, Capital Health

Dr. David Haynor

M.D., Ph.D., Neuro-radiologist and Assistant Professor of Radiology and Neurological Surgery at University of Washington Hospitals